Cargando…
4058 Enhanced efficiency of large-scale clinical proteomic studies: when less is more
OBJECTIVES/GOALS: Large-scale clinical proteomic studies of cancer tissues often entail complex workflows and are resource-intensive. In this study we analyzed ovarian tumors using an emerging, high-throughput proteomic technology termed SWATH. We compared SWATH with the more widely used iTRAQ workf...
Autores principales: | Thomas, Stefani, Friedrich, Betty, Schnaubelt, Michael, Chan, Daniel W., Zhang, Hui, Aebersold, Ruedi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823220/ http://dx.doi.org/10.1017/cts.2020.329 |
Ejemplares similares
-
Orthogonal Proteomic Platforms and Their Implications for the Stable Classification of High-Grade Serous Ovarian Cancer Subtypes
por: Thomas, Stefani N., et al.
Publicado: (2020) -
4429 Powering precision medicine research with the efficient construction of large diverse cohorts
por: Petukhova, Lynn, et al.
Publicado: (2020) -
Urinary proteomics combined with home blood pressure telemonitoring for health care reform trial—First progress report
por: Chori, Babangida S., et al.
Publicado: (2023) -
295 Identification of Proteomic Biomarkers in Puerto Ricans with Pancreatic Cancer
por: Santiago-Gonzalez, Juan C., et al.
Publicado: (2023) -
Large-Scale In Vitro and In Vivo CRISPR-Cas9 Knockout Screens Identify a 16-Gene Fitness Score for Improved Risk Assessment in Acute Myeloid Leukemia
por: Jin, Peng, et al.
Publicado: (2022)